LEXINGTON, Mass., April 22, 2024 (GLOBE NEWSWIRE) Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, today announced that it will present a broad set
LEXINGTON, Mass., April 22, 2024 Voyager Therapeutics, Inc. , a biotechnology company dedicated to advancing neurogenetic medicines, today announced that it will present a broad set of data.